scholarly journals Distinct populations of antigen specific tissue resident CD8 T cells in human cervix mucosa

JCI Insight ◽  
2021 ◽  
Author(s):  
Tao Peng ◽  
Khamsone Phasouk ◽  
Emily Bossard ◽  
Alexis Klock ◽  
Lei Jin ◽  
...  
2016 ◽  
Vol 12 (8) ◽  
pp. e1005799 ◽  
Author(s):  
Heng Giap Woon ◽  
Asolina Braun ◽  
Jane Li ◽  
Corey Smith ◽  
Jarem Edwards ◽  
...  

Science ◽  
2014 ◽  
Vol 346 (6205) ◽  
pp. 101-105 ◽  
Author(s):  
Silvia Ariotti ◽  
Marc A. Hogenbirk ◽  
Feline E. Dijkgraaf ◽  
Lindy L. Visser ◽  
Mirjam E. Hoekstra ◽  
...  

After an infection, pathogen-specific tissue-resident memory T cells (TRM cells) persist in nonlymphoid tissues to provide rapid control upon reinfection, and vaccination strategies that create TRM cell pools at sites of pathogen entry are therefore attractive. However, it is not well understood how TRM cells provide such pathogen protection. Here, we demonstrate that activated TRM cells in mouse skin profoundly alter the local tissue environment by inducing a number of broadly active antiviral and antibacterial genes. This “pathogen alert” allows skin TRM cells to protect against an antigenically unrelated virus. These data describe a mechanism by which tissue-resident memory CD8+ T cells protect previously infected sites that is rapid, amplifies the activation of a small number of cells into an organ-wide response, and has the capacity to control escape variants.


2020 ◽  
Vol 191 ◽  
pp. 111351
Author(s):  
Akanksha Panwar ◽  
Michelle Jhun ◽  
Altan Rentsendorj ◽  
Armen Mardiros ◽  
Ryan Cordner ◽  
...  

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Brandon J. Burbach ◽  
Stephen D. O’Flanagan ◽  
Qi Shao ◽  
Katharine M. Young ◽  
Joseph R. Slaughter ◽  
...  

AbstractMemory CD8+ T cells populate non-lymphoid tissues (NLTs) following pathogen infection, but little is known about the establishment of endogenous tumor-specific tissue-resident memory T cells (TRM) during cancer immunotherapy. Using a transplantable mouse model of prostate carcinoma, here we report that tumor challenge leads to expansion of naïve neoantigen-specific CD8+ T cells and formation of a small population of non-recirculating TRM in several NLTs. Primary tumor destruction by irreversible electroporation (IRE), followed by anti-CTLA-4 immune checkpoint inhibitor (ICI), promotes robust expansion of tumor-specific CD8+ T cells in blood, tumor, and NLTs. Parabiosis studies confirm that TRM establishment following dual therapy is associated with tumor remission in a subset of cases and protection from subsequent tumor challenge. Addition of anti-PD-1 following dual IRE + anti-CTLA-4 treatment blocks tumor growth in non-responsive cases. This work indicates that focal tumor destruction using IRE combined with ICI is a potent in situ tumor vaccination strategy that generates protective tumor-specific TRM.


Author(s):  
Manuel Reithofer ◽  
Sandra Rosskopf ◽  
Judith Leitner ◽  
Claire Battin ◽  
Barbara Bohle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document